Search - tctmd.com

Displaying 81 - 100 of 137

Sort: Relevancy | Date

News Industry News

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

October 12, 2015

News Industry News

ABSORB II: Two-Year Data From The First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes

October 12, 2015

News Conference News TCT 2015

ABSORB II: Absorb BVS, Xience Yield Similar Outcomes at 2 Years

October 12, 2015

News Conference News TCT 2015

Absorb BVS Matches Xience V in Chinese Patients

Todd Neale

October 12, 2015

News Conference News TCT 2015

Novel Devices Present New Treatment Options for STEMI

Yael L. Maxwell

October 11, 2015

News Conference News ESC 2015

ABSORB Trials Pit BRS Against Second-Generation DES

Caitlin E. Cox

September 02, 2015

News Industry News

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

September 01, 2015

News Daily News

登记研究表明 Absorb BVS 治疗所有糖尿病患者的效果与 DES 相当

August 27, 2015

News Daily News

Un Estudio de Registro Sugiere que AVB y SLF son Iguales en Pacientes Diabéticos No Seleccionados

August 27, 2015

News Daily News

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

August 27, 2015

News Industry News

U.S. to vie with India for top bioabsorbable stent market after FDA approval

June 25, 2015

Presentation CCVVC 2015

Vascular Response to BVS

Presenter: Nick West

June 19, 2015

News Industry News

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

May 19, 2015

News Industry News

India Coronary Stent Market to be Tripled by 2021

May 05, 2015

News Daily News

积极准备下钙化灶 BRS 置入可行

April 29, 2015

News Daily News

BRS Use in Calcified Lesions Feasible With Aggressive Preparation

April 29, 2015

Presentation ARCH 2015

DEB - BVS

Presenter: George S. Chrysant

April 10, 2015

Presentation

Comparison of Everolimus- and Biolimus-Eluting Coronary Stents with Everolimus-Eluting BVS

Presenter: A.Puricel

February 26, 2015

News Daily News

EVERBIO II Published: BVS Matches Leading DES for Midterm Outcomes

L.A. McKeown

February 26, 2015

Presentation BRS 2015

My greatest long-term BVS success

Presenter: A. S. Petronio

February 10, 2015

Advertisement

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

ABSORB II: Two-Year Data From The First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes

ABSORB II: Absorb BVS, Xience Yield Similar Outcomes at 2 Years

Absorb BVS Matches Xience V in Chinese Patients

Novel Devices Present New Treatment Options for STEMI

ABSORB Trials Pit BRS Against Second-Generation DES

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

登记研究表明 Absorb BVS 治疗所有糖尿病患者的效果与 DES 相当

Un Estudio de Registro Sugiere que AVB y SLF son Iguales en Pacientes Diabéticos No Seleccionados

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

U.S. to vie with India for top bioabsorbable stent market after FDA approval

Vascular Response to BVS

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

India Coronary Stent Market to be Tripled by 2021

积极准备下钙化灶 BRS 置入可行

BRS Use in Calcified Lesions Feasible With Aggressive Preparation

DEB - BVS

Comparison of Everolimus- and Biolimus-Eluting Coronary Stents with Everolimus-Eluting BVS

EVERBIO II Published: BVS Matches Leading DES for Midterm Outcomes

My greatest long-term BVS success

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content